Apollo Care, LLC SEMAGLUTIDE 7.5mg Recall (December 2026)
Announced 2026-08-19 · FDA
The recall involves Apollo Care, LLC SEMAGLUTIDE 7.5mg (5mg/mL) with Glycine 7.5 mg (5mg/mL) in a 1.5 mL sterile multi-dose vial, Rx Only, for subcutaneous injection. The issue is the presence of particulate matter identified as nylon/polyamide and silk/proteinaceous-type material. The affected lot is AC-017272, expiring 12/12/2026, distributed nationwide in the United States.
| Brand | Apollo Care, LLC |
|---|---|
| Product | SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03 |
| Reason | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material |
| Severity | moderate |
| Units affected | 250 |
| Distribution | Nationwide within the U.S |
| Agency | FDA |
| Recall / campaign no. | Lot: AC-017272, Exp. 12/12/2026. |
WHAT YOU SHOULD DO
- Do not use any vials from Lot AC-017272.
- Contact your healthcare provider or pharmacist for disposal, return, or replacement instructions.
- Check the lot number on your vial to confirm if it is part of this recall.
- Follow the manufacturer’s or FDA guidance for returning or disposing of the product.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.